Literature DB >> 25944228

Fungal infections in intestinal and multivisceral transplant recipients.

Diana F Florescu1, Uriel Sandkovsky.   

Abstract

PURPOSE OF REVIEW: Patients who undergo intestinal and multivisceral transplantation are at increased risk for infectious complications. Fungal infections are major causes of morbidity and mortality in these patients. The current review highlights key diagnostic and management issues in this population. RECENT
FINDINGS: Invasive infections caused by Candida spp. remain the most common invasive fungal infections in intestinal and multivisceral transplant recipients. Aspergillus is an emerging pathogen but data are limited to case reports or case series. Other fungi including the mucorales, Cryptococcus and endemic mycoses are emerging pathogens but data regarding incidence and timing of disease in intestinal and multivisceral transplant recipients are lacking.
SUMMARY: Invasive candidiasis is the most common fungal infection in patients with intestinal and multivisceral transplants. Experience for diagnosis and management comes from case series and single centers. Diagnosis and management of infections caused by other pathogens such as Aspergillus, Cryptococcus, Mucor, and endemic mycoses is usually extrapolated from other solid organ transplant recipients.

Entities:  

Mesh:

Year:  2015        PMID: 25944228     DOI: 10.1097/MOT.0000000000000188

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  2 in total

1.  Successful Treatment of Recurrent Pulmonary Mucormycosis in a Renal Transplant Patient: A Case Report and Literature Review.

Authors:  Morgan S Martin; Alison A Smith; Monica Lobo; Anil S Paramesh
Journal:  Case Rep Transplant       Date:  2017-03-13

2.  Emerging of Fatal Colitis with Multidrug-Resistant Candida glabrata after Small Bowel Transplantation.

Authors:  Zahra Zareshahrabadi; Mojtaba Shafiekhani; Hamed Nikoupour; Hasti Nouraei; Hamid Morovati; Kamiar Zomorodian
Journal:  Case Rep Transplant       Date:  2021-09-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.